help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on February 21, 2008, doi:10.1164/rccm.200712-1841OC

Am. J. Respir. Crit. Care Med., Volume 177, Number 10, May 2008, 1122-1127

A more recent version of this article appeared on May 15, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200712-1841OCv1
177/10/1122    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Condliffe, R.
Right arrow Articles by Pepke-Zaba, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Condliffe, R.
Right arrow Articles by Pepke-Zaba, J.

Submitted on December 17, 2007
Accepted on February 21, 2008

Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension

Robin Condliffe1, David G Kiely2, J Simon R Gibbs3, Paul A Corris4, Andrew J Peacock5, David P Jenkins6, Denise Hodgkins6, Kim Goldsmith6, Rodney J Hughes6, Karen Sheares6, Steven SL Tsui6, Iain J Armstrong2, Chantal Torpy3, Rachel Crackett7, Christopher M Carlin5, Clare Das8, J Gerry Coghlan8, and Joanna Pepke-Zaba6*

1 Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom; Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom, 2 Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom, 3 Department of Cardiology, Hammersmith Hospital, London, United Kingdom, 4 Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom; Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom, 5 Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, United Kingdom, 6 Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom, 7 Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom, 8 Department of Cardiology, Royal Free Hospital, London, United Kingdom

* To whom correspondence should be addressed. E-mail: joanna.pepkezaba{at}papworth.nhs.uk.

Rationale: The management of chronic thromboembolic pulmonary hypertension (CTEPH) has changed over recent years with the growth of pulmonary endarterectomy surgery and the availability of disease-modifying therapies. Objectives: To investigate the prognosis of CTEPH in a national setting during this recent period. Methods: All incident cases diagnosed in one of the 5 pulmonary hypertension centres in the UK between January 2001 and June 2006 were identified prospectively. Information regarding baseline characteristics, treatment and follow-up was subsequently collected from hospital records. Measurements and Main Results: 469 patients were diagnosed of which 148 (32%) had distal, non-surgical disease. One and three year survival from diagnosis was 82% and 70% for patients with non-surgical disease and 88% and 76% for those treated surgically (p=0.023). Initial functional improvement in patients with non-surgical disease was noted but did not persist at 2 years. Significant functional and haemodynamic improvements were seen in surgically-treated patients with an increase in six minute walk distance of 105 m (p<0.001) at 3 months. Five year survival from surgery in the 35% of patients who survived to three months but had persistent pulmonary hypertension was 94%. Conclusions: The prognosis in non-surgical disease has improved. We have confirmed the previously described good outcome in surgically-treated disease. However, we have also demonstrated that the long term prognosis for patients who have persistent pulmonary hypertension at 3 months following surgery is good. The observed improvements in outcome during the modern treatment era reinforce the importance of identifying patients with this increasingly treatable condition.


Key words: pulmonary hypertension, thromboembolism, endarterectomy, survival, drug therapy




This article has been cited by other articles:


Home page
Eur Heart JHome page
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537.
[Full Text] [PDF]


Home page
ERRHome page
C. M. Kahler
Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history
Eur. Respir. Rev., September 1, 2009; 18(113): 170 - 173.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S85 - S96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Hypertension 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 650 - 656.
[Full Text] [PDF]


Home page
ERRHome page
I. M. Lang
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Eur. Respir. Rev., March 1, 2009; 18(111): 24 - 28.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Couturaud, I. Frachon, and C. Leroyer
Chronic thromboembolic pulmonary hypertension: a tribute to pulmonary endarterectomy
Eur. Respir. J., February 1, 2009; 33(2): 230 - 232.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. K. Johnson, W. N. Lee, M. W. Sproule, and A. J. Peacock
Regional variations in pulmonary endarterectomy rates within the UK
Eur. Respir. J., February 1, 2009; 33(2): 453 - 454.
[Full Text] [PDF]


Home page
Eur Respir JHome page
R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. J. Peacock, D. P. Jenkins, K. Goldsmith, J. G. Coghlan, and J. Pepke-Zaba
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension
Eur. Respir. J., February 1, 2009; 33(2): 332 - 338.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Jais, A. M. D'Armini, P. Jansa, A. Torbicki, M. Delcroix, H. A. Ghofrani, M. M. Hoeper, I. M. Lang, E. Mayer, J. Pepke-Zaba, et al.
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2127 - 2134.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al.
Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. G. Corsico, A. M. D'Armini, I. Cerveri, C. Klersy, E. Ansaldo, R. Niniano, E. Gatto, C. Monterosso, M. Morsolini, S. Nicolardi, et al.
Long-term Outcome after Pulmonary Endarterectomy
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 419 - 424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  2nd Annual Dinner